Befesa SA (BFSA)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 31.65 |
|---|---|
| 52-week range | 26.60 – 38.10 |
| Return, 1 month / 3 months | −6.9% / −8.8% |
| Return, 1 year / 3 years | +7.4% / +30.4% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 32.5% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 2.42M EUR |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Befesa is a Spanish company that provides recycling and environmental services to the steel and aluminium industries. It collects dust and residues from steelmaking furnaces and recovers zinc and other metals from them, and it also handles aluminium residues and salt slags. Its customers are steel mills, aluminium producers and other industrial firms that need their hazardous by-products treated and reclaimed. The company is based in Spain and operates facilities across Europe and other regions.
On this site Befesa SA appears as a stock on the XETRA Stock Exchange (Germany), code BFSA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Befesa SA (BFSA) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 31.65 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 215 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.4% and over the last three months it fell 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.0% | ||
| From 52-week high | -16.6% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.8% | ||
| 6-month return | -6.5% | ||
| 12-month return, skipping the last month | 15.4% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 2.42M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −6.9% |
|---|---|
| 1 month | −6.9% |
| 3 months | −8.8% |
| 6 months | −6.5% |
| 1 year | +7.4% |
| 3 years | +30.4% |
| 5 years | −48.8% |
Signals
| 50-day / 200-day average | 35.09 / 32.97 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.06 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2026 | EUR 1.0000 |
| 20 Jun 2025 | EUR 0.6400 |
| 21 Jun 2024 | EUR 0.7300 |
| 16 Jun 2023 | EUR 0.7300 |
| 17 Jun 2022 | EUR 1.2500 |
| 1 Jul 2021 | EUR 1.1700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.